Internal medicine, Endocrinology, Fatty liver, Gastroenterology and Nonalcoholic fatty liver disease are his primary areas of study. Much of his study explores Internal medicine relationship to Diabetes mellitus. As a part of the same scientific family, Giulio Marchesini mostly works in the field of Endocrinology, focusing on Randomized controlled trial and, on occasion, Placebo and Clinical trial.
Giulio Marchesini studies Fatty liver, namely Steatohepatitis. His Gastroenterology research includes themes of Odds ratio, Biopsy, Hepatitis C and Risk factor. The study incorporates disciplines such as Hemochromatosis, Lipogenesis, Liver biopsy, Hepatic fibrosis and Hepatology in addition to Nonalcoholic fatty liver disease.
His main research concerns Internal medicine, Endocrinology, Gastroenterology, Cirrhosis and Fatty liver. In his study, which falls under the umbrella issue of Internal medicine, Intensive care medicine is strongly linked to Diabetes mellitus. Endocrinology is closely attributed to Amino acid in his work.
His work in Gastroenterology covers topics such as Odds ratio which are related to areas like Confidence interval. Giulio Marchesini combines subjects such as Hepatocellular carcinoma and Liver function with his study of Cirrhosis. Giulio Marchesini focuses mostly in the field of Fatty liver, narrowing it down to topics relating to Weight loss and, in certain cases, Binge eating.
Giulio Marchesini mainly focuses on Internal medicine, Fatty liver, Diabetes mellitus, Nonalcoholic fatty liver disease and Gastroenterology. His Internal medicine research incorporates elements of Endocrinology and Type 2 diabetes. His studies in Fatty liver integrate themes in fields like Steatosis and Hepatology.
His Diabetes mellitus study combines topics from a wide range of disciplines, such as Insulin, Pediatrics and Emergency medicine. The various areas that he examines in his Nonalcoholic fatty liver disease study include Lipogenesis, Metabolic syndrome, Liver transplantation and Lipotoxicity. His research integrates issues of Overweight, Biopsy and Severity of illness in his study of Gastroenterology.
His primary areas of study are Internal medicine, Fatty liver, Nonalcoholic fatty liver disease, Liver disease and Endocrinology. His research in Internal medicine intersects with topics in Gastroenterology and Type 2 diabetes. His Fatty liver study improves the overall literature in Disease.
His work deals with themes such as Cirrhosis and Liver transplantation, which intersect with Nonalcoholic fatty liver disease. Giulio Marchesini has researched Liver disease in several fields, including Diabetes mellitus, Metabolic syndrome, Insulin resistance and Hepatic encephalopathy. His research in Endocrinology focuses on subjects like Gut flora, which are connected to Adiponutrin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
Giulio Marchesini;Christopher P. Day;Jean Francois Dufour;Ali Canbay.
Journal of Hepatology (2016)
Nonalcoholic fatty liver disease a feature of the metabolic syndrome
Giulio Marchesini;Mara Brizi;Giampaolo Bianchi;Sara Tomassetti.
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo;Jason M. Hui;Giulio Marchesini;Ellisabetta Bugianesi.
Association of nonalcoholic fatty liver disease with insulin resistance
Giulio Marchesini;Mara Brizi;Antonio M Morselli-Labate;Giampaolo Bianchi.
The American Journal of Medicine (1999)
Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma
Elisabetta Bugianesi;Nicola Leone;Ester Vanni;Giulio Marchesini.
Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study†‡
Giorgio Bedogni;Lucia Miglioli;Flora Masutti;Claudio Tiribelli.
A position statement on NAFLD/NASH based on the EASL 2009 special conference ☆
Vlad Ratziu;Stefano Bellentani;Helena Cortez-Pinto;Chris Day.
Journal of Hepatology (2010)
Metformin in non-alcoholic steatohepatitis.
Giulio Marchesini;Giampaolo Bianchi;Sara Tomassetti;Marco Zoli.
The Lancet (2001)
Insulin resistance: A metabolic pathway to chronic liver disease†
Elisabetta Bugianesi;Arthur J. McCullough;Giulio Marchesini.
Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes
Yngve Falck-Ytter;Zobair M. Younossi;Giulio Marchesini;Arthur J. McCullough.
Seminars in Liver Disease (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: